NTRA

#434
Natera, Inc. - Common Stock
220.8 7 USD
+3.14%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
211.40
221.50
Range Annuel
131.81
256.27
Changement quotidien
+3.14%
Changement Mensuel
+11.90%
Evolution sur 6 mois
-7.44%
Changement Annuel
+40.23%
Clôture Précédente
214.1 4
Open
214.9 7
Low
211.4 0
High
221.5 0
Volume
638
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 31.63 B
  • Employee 6 140
  • Founded 2004
  • CEO Steven Chapman
  • Website www.natera.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BQ86
  • Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-150.72
ratio cours/chiffre d'affaires
13.58

Natera, Inc. - Common Stock

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

Nouvelles